The impact of market volatility on the cell therapy industry

Cell Stem Cell. 2011 Nov 4;9(5):397-401. doi: 10.1016/j.stem.2011.10.010.


Stock market volatility in the cell therapy industry has greatly hindered the investment necessary to fund translational therapies. Here, we review the volatility of leading companies and suggest that a distinct industry is maturing to a point at which the volatility should subside, providing a more attractive environment for future growth.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Industry / economics*
  • Humans
  • Marketing / economics*
  • Stem Cell Transplantation / economics*
  • Time Factors
  • Uncertainty